Lefamulin

(Xenleta®)

Lefamulin

Drug updated on 11/14/2023

Dosage FormInjection (intravenous: 150 mg/15 mL of 0.9% sodium chloride); Tablet (oral: 600 mg)
Drug ClassPleuromutilin antibacterials
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For the treatment of adults with community-acquired bacterial pneumonia (CABP) caused by susceptible microorganisms.

Product Monograph / Prescribing Information

Document TitleYearSource
Xenleta (lefamulin) Prescribing Information2021Nabriva Therapeutics US Inc., Fort Washington, PA

Systematic Reviews / Meta-Analyses